Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study.
OBJECTIVE
Our aim was to estimate the prevalence of distal chronic pain with neuropathic characteristics in patients with type 1 and type 2 diabetes mellitus and its impact on quality of life, mood, anxiety, sleep and healthcare utilization.


METHODS
In total, 885 patients were screened and 766 diabetic patients (38.7% with type 1 diabetes mellitus, 44.8% women, mean age: 57.2 ± 14.9 years) were enrolled consecutively over a three-month period in this observational study by 85 diabetes specialists working in a hospital department or in private practice. All the patients completed a series of questionnaires for the detection of chronic pain (i.e. daily pain for more than three months) in the lower limbs and assessment of health-related quality of life (Medical Outcomes Short Form 12 scale), sleep disturbances (MOS sleep scale), depression and anxiety (Hospital Anxiety and Depression scale). Patients with chronic pain were also assessed with the 7-item DN4-interview questionnaire, the monofilament test and the Michigan Neuropathy Screening Instrument (MNSI).


RESULTS
The overall prevalence of chronic pain with neuropathic characteristics was 20.3% [95% CI 17.4-23.1]. The MNSI examination score suggested that pain was related to polyneuropathy, in 80.1% of these patients (89.5% of those with bilateral pain). Patients with chronic pain had a poorer quality of life and more sleep disturbances, anxiety and depression than patients without pain and the presence of neuropathic characteristics was predictive of such impairments. Only 38.6% of the patients had received appropriate treatment for neuropathic pain.


CONCLUSIONS
Chronic pain with neuropathic characteristics concerns one in five diabetic patients, has a significant impact on quality of life and is not adequately managed. The close correlation between the DN4 questionnaire and MNSI results suggests that screening tools for neuropathic pain could be used in daily practice for the identification of painful diabetic polyneuropathy.
INSERM U-987, Centre d'Evaluation et Traitement de la Douleur, CHU Ambroise Paré, APHP, Boulogne-Billancourt, France ; Université Versailles-Saint-Quentin, Versailles, France.
Didier
D
Bouhassira
Martine
M
Letanoux
Agnès
A
Hartemann
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D059350:Chronic Pain / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D003430:Cross-Sectional Studies; D003863:Depression / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012893:Sleep Wake Disorders / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D011795:Surveys and Questionnaires